Tech Company Financing Transactions
GENEWIZ Funding Round
GENEWIZ, based in South Plainfield, scored investment capital from OrbiMed and Prime Ventures.
Transaction Overview
Company Name
Announced On
1/13/2016
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
OrbiMed (Lead Investor) (Jonathan Wang)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
115 Corporate Blvd.
South Plainfield, NJ 07080
USA
South Plainfield, NJ 07080
USA
Phone
Website
Email Address
Not Recorded
Overview
GENEWIZ is a contract research organization specializing in DNA sequencing, gene synthesis, plasmid preparation, site-directed mutagenesis, fragment analysis, SNP discovery sequencing, GLP/cGMP regulatory services, next generation sequencing, bioinformatics, and other molecular biology and genomic services.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steve Sun
Chief Operating Officer
Amy Liao
Browse more venture capital transactions:
Prev: 1/13/2016: Syros Pharmaceuticals venture capital transaction
Next: 1/13/2016: Shape Security venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs